Regencell Bioscience Holdings Ltd

NASDAQ RGC

Download Data

Regencell Bioscience Holdings Ltd Asset Turnover Ratio 3 year CAGR for the Trailing 12 Months (TTM) ending September 30, 2022

Regencell Bioscience Holdings Ltd Asset Turnover Ratio 3 year CAGR is NA for the Trailing 12 Months (TTM) ending September 30, 2022. The asset turnover ratio measures a company's efficiency in utilizing its assets to generate revenue. It is calculated by dividing the company's revenue by the average of its total assets and total non-current assets. This ratio indicates how effectively a company generates sales from its asset base. A higher ratio implies better asset utilization and revenue generation, while a lower ratio may suggest underutilization of assets or inefficient operations. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • Regencell Bioscience Holdings Ltd Asset Turnover Ratio for the Trailing 12 Months (TTM) ending December 31, 2021 was -13,475.27.
  • Regencell Bioscience Holdings Ltd Asset Turnover Ratio for the Trailing 12 Months (TTM) ending December 31, 2017 was 0.57, a -7.16% change year over year.
  • Regencell Bioscience Holdings Ltd Asset Turnover Ratio for the Trailing 12 Months (TTM) ending December 31, 2016 was 0.62.
NASDAQ: RGC

Regencell Bioscience Holdings Ltd

CEO Mr. Yat-Gai Au
IPO Date July 16, 2021
Location Hong Kong
Headquarters First Commercial Building, Causeway Bay, Hong Kong
Employees 12
Sector Healthcare
Industry Drug manufacturers - specialty & generic
Description

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Similar companies

EGRX

Eagle Pharmaceuticals Inc

NA

NA

PAHC

Phibro Animal Health Corporation

NA

NA

PROC

Procaps Group SA

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email